Cancer Prevention & Control Program


The goal of the Cancer Prevention & Control Program is to apply the expertise of behavioral, basic, and clinician-scientists to conduct innovative and impactful cancer research that reduces Colorado’s cancer burden. To achieve this goal, CPC brings together outstanding transdisciplinary, well-funded scientists with strengths in public health, psychology, epidemiology, economics, basic science, and cancer care delivery. The program has 57 members, including 43 full members and 14 mentored members from many institutions and represents 24 departments and 7 schools; most members hold primary affiliations with the University of Colorado Anschutz Medical Center, University of Colorado Boulder, and Colorado State University.

Scientific Goals:

  • Discover and evaluate novel approaches to cancer prevention and early detection
  • Conduct population-based cancer control interventions
  • Identify and diminish cancer disparities through health services and policy research

Focus Groups:

  • Population Sciences Research
  • Behavioral Research in Primary and Secondary Prevention 
  • Chemoprevention Research 
  • Cancer Outcomes and Survivorship Research


Cancer Prevention and Control research has led to advancements in primary and clinical preventive services, statewide policies, and improved cancer survivorship. Cancer Prevention and Control investigators studied promising agents in pre-clinical studies, identified breast cancer risk factors in Hispanic women, developed and operated the Colorado Colorectal Screening Program, made advancements in the understanding of obesity and breast cancer, and affected cancer prevention and control policy across the state.

Cancer Prevention and Control Leadership

Jamie Studts PhD

Jamie Studts, PhD

Program Co-Leader

Dr. Studts is a Professor in the Division of Medical Oncology, Department of Medicine in the School of Medicine at the University of Colorado Denver. Dr. Studts is a funded cancer prevention and control scientist for nearly 20 years. His research develops, evaluates, and disseminates interventions to improve outcomes regarding lung cancer screening and lung cancer survivorship. He has served on a broad range of national study sections for NIH and DOD as well as international review panels for the Canadian Cancer Society Research Institute, including a combination of special emphasis panels, standing study sections, and career development panels. Dr. Studts has nearly 100 peer-reviewed scientific publications, and his current research is funded by NCI and the Bristol-Myers Squibb Foundation/LUNGevity Foundation. Dr. Studts has served as Co-Leader of CPC and Co-Director of the Population Health Shared Resource since joining the faculty of the University of Colorado School of Medicine in January 2020. As CPC Co-Leader, Dr. Studts oversees social and population science within the CPC program—across the three program aims and two over-arching UCCC themes. Dr. Studts works closely with Dr. Agarwal to support collaborative research within CPC, across the UCCC research programs, and with cancer prevention and control investigators at other NCI-designated cancer centers.

Rajesh Agarwal, PhD

Program Co-Leader

Dr. Agarwal is a Professor in the Department of Pharmaceutical Sciences in the School of Pharmacy at the University of Colorado Denver. Dr. Agarwal is an NIH-funded cancer chemoprevention scientist for over 30 years. His research interests include chemoprevention of skin, prostate, bladder, colon, lung, pancreatic, and head and neck cancers and a wide range of naturally occurring and synthetic agents to prevent and treat cancer. He has served on numerous study sections and ad hoc review committees at NIH (mostly NCAAM and NCI) involving reviews of Cancer Centers, Program Projects, Botanical and/or Dietary Centers, and R applications. Agarwal has over 400 peer-reviewed scientific publications. His current NCI-funded research portfolio includes an active R01 grant. Dr. Agarwal has been the Co-Leader for the Cancer Prevention and Control Program since July 2009. In this position, he has played a major role in developing and enhancing the CPC’s portfolio of translational chemoprevention and immunoprevention research from bench to bedside, as well as worked closely with his other program co-Leader and other UCCC program leaders, in supporting and integrating cancer chemoprevention research within CPC and other programs at UCCC.


Cancer Prevention and Control Virtual Seminar Series

All events are the second Wednesday of the month and held from Noon to 1 p.m. on Zoom.

Contact for questions.

Most Recent Event

Past Events

Preference Assessment Methods: Use in Cancer Care and Medical Decision-Making Research
Marilyn M. Schapira, MD, MPH

Yoga for the Treatment of Insomnia and Fatigue Among Cancer Survivors
Karen Mustian, PhD, MPH

Beyond a Closed Ended Question: Exploring the Decision to Screen or Not for Lung Cancer
Lisa Carter-Harris, PhD, APRN, ANP-C, FAAN

Epidemiology of Multiple Myeloma and Related Precursor States - A Model for Early Detection
Elizabeth E. Brown, PhD, MPH

Ovarian Cancer: Epidemiologic Research and Future Challenges
Linda Cook, PhD

Cancer Disparities in the 21st Century
Robert A. Winn, MD | VCU